Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PDA Union case involving Boots delayed for four weeks, says CAC

The Central Arbitration Committee which is assessing whether the PDA Union should represent Boots’ pharmacists on matters of pay and holidays has confirmed to PJ Online that it has put the case on hold pending the “final outcome” of the judicial review, which made an interim decision last week.

Simon Gouldstone, the chief executive officer of the CAC, said the CAC was awaiting the High Court’s final order. The judge, Mr Justice Keith, had said at the time: “It is not appropriate for me to make any final order on this claim until the PDAU has had a chance to consider whether to apply in this litigation for a declaration of incompatibility.” At stake is whether UK law is compatible with article 11 of the European Convention on Human Rights, which deals in part with trade unions.

Peter Bainbridge, director of pharmacy at Boots UK,  said: “It continues to be my strong belief that it’s not in the best interest of the future of pharmacy, pharmacy patients or our pharmacists to formally recognise the PDAU for collective bargaining on pay, hours and holidays. While there is much we can agree upon, the PDAU sees the future of pharmacy in a fundamentally different way to us in some key areas.

“We welcome this confirmation from the Central Arbitration Committee as it allows all parties time to consider and understand the implications and effects of the High Court’s decision upon our pharmacists, our business and our relationships with trade unions.”

John Murphy, director of the PDA Union, said: “The PDAU is currently considering its position on applying for a declaration of incompatibility and whether to seek leave to appeal [to the High Court].”

· This article story was amended on 4 February 2014 to include a comment from John Murphy.

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11133761

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Prescribing Adult Intravenous Nutrition

    Prescribing Adult Intravenous Nutrition

    A practical guide to the principles and practice of adult intravenous nutrition. With numerous illustrations and case studies.

    £40.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Community Pharmacy Handbook

    Community Pharmacy Handbook

    Community Pharmacy Handbook is a survival guide for community pharmacists and students, answering your practical questions. Includes case studies.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Boots logo

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.